On a per-share basis, the Rahway, New Jersey-based company said it had profit of $2.01. Earnings, adjusted for one-time gains and costs, came to $2.22 per share. The results exceeded Wall Street ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

Cantor Fitzgerald analyst Carter Gould initiated coverage of Merck (MRK) with a Neutral rating and $85 price target Shares have been “a notable underperformer the past year” as the reset of ...

NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...

Merck & Company (MRK – Research Report) received a Hold rating and an $85.00 price target from Cantor Fitzgerald analyst Carter Gould yesterday. The company’s shares closed yesterday at $77.85 ...

A Merck logo is shown on a scientist's lab coat. The Food and Drug Administration, on Sept. 4, 2014, granted accelerated approval to Merck's Keytruda for treating melanoma that has spread or can't be ...

All products featured on WIRED are independently selected by our editors. However, when you buy something through our retail links, we may earn an affiliate commission. Sensor doesn’t capture ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. New research suggests that playing music in the background could help people with ADHD ...

N EW YORK (Reuters) - Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the U.S. on October 1, and expects ...

Mark Hamill's Luke Skywalker showing up in The Mandalorian remains one of the biggest surprises in Star Wars history, and Rosario Dawson told us at Star Wars Celebration that she had no idea his ...